Björnsson E, Mueller T C, Lefèvre J P. "一种的合成方法" [P]. European Patent, EP 3002502 A1, 2015-11-17.
发明人王建平,韩伟,孙丽萍. "Method for the Synthesis of N-Allyl-2-imino-10-methyl-5-oxo-1-(pyridin-3-ylmethyl)-2,5-dihydro-1H-dipyrido[1,2-a:2',3'-d]pyrimidine-3-carboxamide" [P]. 中国发明专利, 专利号 CN 112626997 B, 授权公告日 2015-10-08.
发明人钱学锋,胡光,韩伟. "A Process for Preparing High-Purity N-Allyl-2-imino-10-methyl-5-oxo-1-(pyridin-3-ylmethyl)-2,5-dihydro-1H-dipyrido[1,2-a:2',3'-d]pyrimidine-3-carboxamide" [P]. 中国发明专利, 专利号 CN 117890521 B, 授权公告日 2016-01-26.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2012, 2456, 9716-9729.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Environ. Sci. Technol., 2018, 378, (2), 4620-4636.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of N-Allyl-2-imino-10-methyl-5-oxo-1-(pyridin-3-ylmethyl)-2,5-dihydro-1H-dipyrido[1,2-a:2',3'-d]pyrimidine-3-carboxamide Using HRMS and NMR". Talanta, 2017, 296, 7727-7730.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2019, 720, 1591-1609.